On October 27, Albemarle rose 5.17% in Regular Trading, trading at $98.45 per share, with turnover of $20.868 million.
The clearest disclosed catalyst was the company’s announcement that it kept its quarterly dividend unchanged at $0.41 per share, payable on January 4 to shareholders of record on December 18.
The dividend update followed a period of downward analyst target revisions. In recent weeks, Citigroup cut its price target to $125 from $175, BofA Securities lowered its target to $131 from $155 while maintaining a Buy rating, RBC reduced its target to $129 from $157 with an Outperform rating, and Barclays initiated coverage at Equalweight with a $109 target. Those changes indicate that, despite the day’s rise, the broader backdrop for Albemarle remains shaped by cautious lithium-market expectations.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments